AMP.MI · MIL · Healthcare
Amplifon S.p.A.
Also onConsensus Drift
Implied value per share
EUR 14.80
Market price
EUR 11.39
Implied upside
+29.9%
5-year forecast · Perpetuity growth terminal value · Mid-year discounting · Base case
Value Per Share
Same forecast, different terminal treatment. Percentages vs price.
Forecast Cashflows
Reporting currency (EUR). Outflows negative.
| Line | FY26 | FY27 | FY28 | FY29 | FY30 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | EUR 2.5bn | EUR 2.6bn | EUR 2.7bn | EUR 2.8bn | EUR 2.9bn | +4.2% |
| EBIT | EUR 266.8m | EUR 277.9m | EUR 289.5m | EUR 301.6m | EUR 314.2m | +4.2% |
| NOPAT | EUR 200.1m | EUR 208.4m | EUR 217.1m | EUR 226.2m | EUR 235.6m | +4.2% |
| Add depreciation & amortisation | EUR 305.0m | EUR 317.7m | EUR 331.0m | EUR 344.8m | EUR 359.2m | +4.2% |
| Less capital expenditure | EUR -141.9m | EUR -147.8m | EUR -154.0m | EUR -160.4m | EUR -167.1m | +4.2% |
| Less increase in working capital | EUR -6.3m | EUR -6.5m | EUR -6.8m | EUR -7.1m | EUR -7.4m | +4.2% |
| Free cashflow to firm | EUR 356.9m | EUR 371.8m | EUR 387.3m | EUR 403.5m | EUR 420.3m | +4.2% |
| Discount factor | 0.9630 | 0.8930 | 0.8280 | 0.7678 | 0.7120 | - |
| Present value | EUR 343.7m | EUR 332.0m | EUR 320.7m | EUR 309.8m | EUR 299.3m | -3.4% |
| Present Value Of The Forecast | EUR 1.6bn | |||||
Discount Rate
Source shown per component. All overridable above.
| Risk-free rate | 4.20% | USD assumption - no free live source available for this market (assumption) |
| Equity risk premium | 6.50% | Market assumption |
| Beta | 0.994 | Reported 0.991, pulled toward 1.0 (Blume) |
| Cost of equity | 10.66% | Risk-free + beta x equity risk premium |
| Cost of debt | 4.20% | Floored at the risk-free rate (implied cost of debt was lower) |
| Market capitalisation | EUR 3.0bn | 62.4% of capital |
| Total debt | EUR 1.8bn | 37.6% of capital, book value as a proxy |
| Tax rate | 25.0% | Effective, capped at statutory |
| WACC | 7.84% | E/V x Re + D/V x Rd x (1 - t) |
Terminal Value
Perpetuity growth is intrinsic. The exit multiple defaults to the company's current EV/EBITDA, so it answers a different question - what the shares are worth if today's rating holds and EBITDA grows as forecast.
Perpetuity growth at 2.50%
66% of EV
- Forecast FCFF, final year
- EUR 420.3m
- Capex at depreciation, working capital in reinvestment
- EUR 328.5m
- Less reinvestment at g/ROIC (29.6% of NOPAT)
- EUR -97.2m
- Capitalised
- EUR 231.3m
- ROIC (reported)
- 8.5%
- Terminal value, undiscounted
- EUR 4.4bn
- Terminal value, discounted
- EUR 3.2bn
- Enterprise value
- EUR 4.8bn
- Less net debt
- EUR 1.5bn
- Equity value
- EUR 3.3bn
Exit at 8.7x EBITDA
72% of EV
- Terminal value, undiscounted
- EUR 5.9bn
- Terminal value, discounted
- EUR 4.2bn
- Enterprise value
- EUR 5.8bn
- Less net debt
- EUR 1.5bn
- Equity value
- EUR 4.3bn
Spread between methods: 27%.
Sensitivity
Value per share (EUR) by discount rate and long-run growth.
| Long-run growth | |||||
|---|---|---|---|---|---|
| Discount rate | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
| 5.84% | 23.02 | 24.22 | 25.77 | 27.83 | 30.74 |
| 6.84% | 17.93 | 18.43 | 19.04 | 19.78 | 20.72 |
| 7.84% | 14.43 | 14.60 | 14.80 | 15.02 | 15.28 |
| 8.84% | 11.98 | 12.04 | 12.09 | 12.15 | 12.21 |
| 9.84% | 10.21 | 10.26 | 10.31 | 10.36 | 10.41 |
Outlined: this model. Green text: above today's price of 11.39. Shading: distance from this model's own value.
Priced In
What each input would have to be to justify the current price, one at a time.
| Input | Model | Implied | Gap |
|---|---|---|---|
| Revenue growth, every year | 4.2% | -0.1% | -4.2pp |
| EBIT margin | 10.7% | 8.2% | -2.5pp |
| Discount rate | 7.8% | 9.2% | +1.4pp |
Live formulas, not pasted numbers - edit a driver and the workbook reprices.
Yahoo Finance and RBA data. General information, not advice. Methodology.